Evotec SE and Owkin, a French-American techbio company today announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-owkin-enter-an-ai-powered-strategic-partnership-to-accelerate-therapeutics-pipeline-in-oncology-and-ii-6362